Moderna | MRNA - Los Ingresos Por Intereses

Precio De Mercado
45.71
Cambio Diario
-1.43 -3.03%
Mensual
-5.23%
Anual
60.16%
Q2 Expectativa
49.64




Los Ingresos Por Intereses Cambio Fecha
Acadia Pharmaceuticals USD 8.25M 1M 2025-09
Agios Pharmaceuticals USD 12.41M 959K 2025-12
Alnylam Pharmaceuticals USD 28.68M 1.19M 2025-09
Arrowhead Research USD 9.05M 1.97M 2025-09
Biogen USD 37.2M 5.6M 2025-12
BioMarin Pharmaceutical USD 17.85M 973K 2025-09
Celltrion KRW 676.66M 6.85B 2025-06
Dianthus Therapeutics USD 3.66M 255K 2025-09
Esperion Therapeutics USD -0.15 0.18 2024-09
Gilead Sciences USD 95M 7M 2025-12
GlaxoSmithKline GBP -74M 100M 2025-12
Incyte USD 30.75M 3.97M 2025-12
Ionis Pharmaceuticals USD -0.66 0.29 2024-12
Kangmei Pharma CNY 1.81M 2.5M 2025-06
Knight Therapeutics CAD 2.46M 498K 2024-09
Laboratorios Farma EUR 139K 42K 2025-06
Moderna USD 73M 8M 2025-09
Pharma Mar EUR 1.63M 3.17M 2025-12
Puma Biotechnology USD 0.41 0.5 2024-09
Qiagen NV USD 20M 4.93M 2025-12
Regeneron Pharmaceuticals USD 193.3M 18.2M 2025-12
Sarepta Therapeutics USD 8.38M 1.24M 2025-09
Sartorius EUR -31.8M 86.7M 2025-12
Tilray USD 12.83M 20.19M 2024-05
Ultragenyx Pharmaceutical USD 5.86M 69K 2025-09
United Therapeutics USD 46.4M 4.9M 2025-09
Vertex Pharmaceuticals USD 125.7M 3.3M 2025-09
Zhangzhou Pientzehuang Pharmaceutical CNY 6.65M 4.01M 2025-06